Overview

Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the bioequivalence of ICI176,334-1 in Japanese healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Bicalutamide